Alerts will be sent to your verified email
Verify EmailASTEC
5
10
20
Astec Lifesciences balance sheet is weak and might have solvency issues
Yes, The net debt of Astec Lifesciences is increasing.
Latest net debt of Astec Lifesciences is ₹549 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹489 Crs.
The profit is oscillating.
The profit of Astec Lifesciences is -₹128.03 Crs for TTM, -₹134.75 Crs for Mar 2025 and -₹46.93 Crs for Mar 2024.
The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Astec Lifesciences latest dividend payout ratio is 11.5% and 3yr average dividend payout ratio is 11.5%
Companies resources are majorly tied in miscellaneous assets